Federal contractor profile
PARATEK PHARMACEUTICALS, INC
UEI D5KEFN62CJ97CAGE 80ES6
Active
Overview
- Legal name
- PARATEK PHARMACEUTICALS, INC
- Registered location
- KING OF PRUSSIA, PA, USA
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Feb 20, 2026
Read company summary
PARATEK PHARMACEUTICALS, INC is associated with UEI D5KEFN62CJ97 and CAGE 80ES6 in public federal records. AcornBids currently links 1 prime award totaling $265.3M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists KING OF PRUSSIA, PA, USA.
At a glance
Lifetime prime obligations$265.3M
Prime awards1
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 9, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- PARATEK PHARMACEUTICALS, INC
- UEI
- D5KEFN62CJ97
- CAGE
- 80ES6
- Registered address
- 1000 1ST AVE STE 200, KING OF PRUSSIA, PA, 19406, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Jul 14, 2026
- Initial registration
- Dec 1, 2017
- Entity start
- Feb 27, 2001
- SAM updated
- Jul 14, 2026
- Registration expires
- Jul 13, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 1 awards and $265,316,226 in reported obligations to this legal entity. Source
- Recorded awards include Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714); this classification is not proof of every company capability. Source
- An example award describes: ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Selected transaction obligations$265.3M
Prime contracts
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 1 of 1 selected awards. Select a period to explore its awards.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75A50120C00001ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION | Department of Health and Human Services | $265.3M | Dec 18, 2019 | Dec 17, 2029 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jul 14, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Dec 1, 2017 |
| Entity start | Feb 27, 2001 |
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| RANDY BRENNER | Government business | Contact method not published | SAM registration | Not available |
| KARY CALLAHAN | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
1 awards
1 awards
1 awards
About PARATEK PHARMACEUTICALS, INC
What products and services appear in its federal awards?
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Recorded products and services: 6505 — Drugs and Biologicals.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
1000 1ST AVE STE 200, KING OF PRUSSIA, Pennsylvania 19406, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit